+358 4170 82703 [email protected]
The burden of AMR and the need for new antibiotics

The burden of AMR and the need for new antibiotics

Ville Kainu MD. PhD. Global Medical Affairs Director, Anti-Infectives Pfizer How to incentivize research and development A few years ago, the WHO developed a priority list of bacteria against which new antibiotics are needed, ranging from critical to medium priority....